Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis

Documenti analoghi

• Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole‐Blood Transcriptomics Data
  di: Chuan Fu Yap, et al.
  Pubblicazione: (2025)
• Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register
  di: Ryan M. Hum, et al.
  Pubblicazione: (2024)
• Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study
  di: Sizheng Steven Zhao, et al.
  Pubblicazione: (2024)
• Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis
  di: Melissa Tordoff, et al.
  Pubblicazione: (2024)
• Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis–Associated Interstitial Lung Disease: An Emulated Target Trial
  di: Po‐Cheng Shih, et al.
  Pubblicazione: (2025)